Biogen Idec, Elan’s partner in the development and sale of Tysabri, is testing the efficacy of a malaria pill developed during the Vietnam war in treating progressive multifocal leukoencephalopathy (PML), the brain infection read more »
1)
This site contains valuable information. I agree with that communication is key to successful pain
2)
Furthermore, SPMS has two stages: with relapses-still in the inflammatory stage and qualifies for Tysabri; without read more »
Clinical data suggests that Bayhill’s lead product candidate BHT-3009 induces the immune system to tolerize to, rather than attack, the MBP in the myelin sheath. BHT-3009 is a plasmid encoding MBP directed specifically at reprogramming read more »
